Dr. Tim Cripe, M.D. Ph.D

Physician-scientist @nationwidekids. Host of This Week in Peds Oncology, the podcast about #kidscancer #childhoodcancer #immunotherapy #genetherapy #oncolytic

[Dr. Tim Cripe, M.D. Ph.D @KidsOncDoc]

Imagine if there was a legal performance enhancing drug that makes you strong enough to resist getting sick from an infection? Even better, you only take it once and you are stronger for life! #vaccinessavelives #preventionisthebestmedicine
#legalPED

[Dr. Tim Cripe, M.D. Ph.D @KidsOncDoc]

.⁦@nationwidekids⁩ ⁦@OhioState⁩ ⁦@StudentLifeOSU⁩ ⁦@BuckeyeThon⁩ #FTK

[Dr. Tim Cripe, M.D. Ph.D @KidsOncDoc]

What a compelling essay. Thank you Craig for being will to share your personal story.

[Jake Scott @CancerConnector]

Great story on our new @vironexis programmable #genetherapy platform to create lifelong t-cell engaging bispecific antibodies from a single infusion - from @Medium

@OncoAlert @oncodaily @MedscapeOnc @nationwidekids

https://t.co/RXVkYcsh9D

[Dr. Tim Cripe, M.D. Ph.D @KidsOncDoc]

Congrats to our collaborative group enabled by the @theNCI PI-DDN.

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Circumventing resistance within the Ewing sarcoma microenvironment by combinatorial innate immunotherapy https://t.co/oV70dWi477 @KidsOncDoc

[Dr. Tim Cripe, M.D. Ph.D @KidsOncDoc]

@AstroGrower @FutureJurvetson @vironexis Phase 1

https://t.co/LFTRPLB73J

[Vironexis Biotherapeutics @vironexis]

Great article by Elizabeth Eaton in @fwpharma about our platform technology, pipeline and mission to transform cancer treatment for patients with AAV-delivered T-cell immunotherapy! See article: https://t.co/DeJCZVZcJQ

[Dr. Tim Cripe, M.D. Ph.D @KidsOncDoc]

Thank you @nationwidekids and @vironexis and especially my outstanding laboratory team at NCH including Mark Currier, Brian Hutzen, Pin-Yi Wang, Chun-Yu Chen, & Andrea Glaspell for making great progress so far! https://t.co/ZIUqg0fywF

[Dr. Tim Cripe, M.D. Ph.D @KidsOncDoc]

Congrats to Dr Paudel for publishing his PhD thesis work from our lab in Frontiers | Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors #MPNST #NF1 #TVEC https://t.co/RYNLic2nL2

[Dr. Tim Cripe, M.D. Ph.D @KidsOncDoc]

Congrats to all graduating ⁦@nationwidekids⁩ hematology/oncology/BMT fellows, especially our 4th year sarcoma fellow Dr Alejandra Rosales, shown here with the sarcoma team doctors. They are lucky to get you ⁦@LSUHealthNO⁩ in Shreveport as a new Assistant Professor!

[Dr. Tim Cripe, M.D. Ph.D @KidsOncDoc]

We still need books

[Dr. Tim Cripe, M.D. Ph.D @KidsOncDoc]

Thanks to @nationwidekids Dr Kevin Cassady for leading this study showing IL12 gene therapy improves oncolytic viroimmunotherapy in preclinical models of #MPNST #sarcoma https://t.co/NKve8vG66Z

[Dr. Tim Cripe, M.D. Ph.D @KidsOncDoc]

Congrats to @nationwidekids Dr Mark Ranalli shown here presenting interim results at #ASCO24 of his clinical trial using adoptive NK cells for pediatric patients with #neuroblastoma (STING) being run through NANT based on our NCH colleague Dr Dean Lee’s work

[Dr. Tim Cripe, M.D. Ph.D @KidsOncDoc]

Thanks to #childhoodcancer research luminaries Drs Jim Armatruda, Brenda Weigel, and Mark Hatley for being external advisors to our ⁦@nationwidekids⁩ @theNCI⁩ funded T32 training program and thanks to our trainees for giving inspiring research talks today! #cancerlauNCH

[Dr. Tim Cripe, M.D. Ph.D @KidsOncDoc]

We are pleased to have ⁦@NeuroOncDoc⁩ delivering our @nationwidekids #childhoodcancer T32 lecture today on the #glioma microenvironment and how he hopes to prevent malignant transformation of low grade to high grade

[Dr. Tim Cripe, M.D. Ph.D @KidsOncDoc]

Reviving the lost art of meeting reports - ScienceDirect https://t.co/4XApElzRrS

[Dr. Tim Cripe, M.D. Ph.D @KidsOncDoc]

Progress in sarcomas: Highlights from the 2023 annual meetingof the Co... https://t.co/IJxozJva1o

[Dr. Tim Cripe, M.D. Ph.D @KidsOncDoc]

It’s a fantastic day for our patients! Thank you for the partnership @OSUCCC

[The James at Ohio State @OSUCCC_James]

It's a great day for #cancer care in Columbus, where we've cut the ribbon on our proton therapy center at The James Outpatient Care. The state-of-the-art center brings effective, precision proton therapy to adult and pediatric cancer patients from The James and @nationwidekids.

[Dr. Tim Cripe, M.D. Ph.D @KidsOncDoc]

.⁦@nationwidekids⁩ welcomes ⁦⁦@BuckeyeThon⁩ tonight!

[Dr. Tim Cripe, M.D. Ph.D @KidsOncDoc]

Congrats to @OhioState Molecular Cellular Developmental Biology PhD candidate Emily Franz comentored by me @nationwidekids and Dr Ryan Roberts @KidCancerLab for her poster award at the international sarcoma mtg in Dublin Ireland #CTOS hopefully she will be submitting paper soon!